Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension.

K, Gohji; N, Fujimoto; I, Hara; A, Fujii; A, Gotoh; H, Okada; S, Arakawa; S, Kitazawa; H, Miyake; S, Kamidono; M, Nakajima

doi:10.1002/(sici)1097-0215(19980220)79:1<96::aid-ijc18>3.0.co;2-f

Public

Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension.

Shared by NobleBlocks on Feb 1, 1998 • 12:00 AM UTC

Authors:

Gohji K

Fujimoto N

Hara I

Abstract

We examined whether the serum matrix metalloproteinase-2 (MMP-2) level and MMP-2 density could be predictors of the development and extension of prostate cancer. Serum samples were collected before any clinical treatment from 98 patients with prostate cancer and from 76 patients with benign prostati...

Discussions